Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bev-IP
2017-004847-19Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Mar 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of bevacizumab in peritoneal carcinomatosis (PC), sponsored by Hospices Civils de Lyon. Started Mar 2018; status: completed.
02
Drugs
bevacizumab
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on 2017-004847-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004847-19.